Can you provide the last earnings date for EIGER BIOPHARMACEUTICALS INC?
EIGER BIOPHARMACEUTICALS INC (EIGR) last reported earnings on 5/11/2023.
EIGER BIOPHARMACEUTICALS INC (EIGR) Earnings History & Surprises
NASDAQ:EIGR • US28249U2042
Current stock price
1.725 USD
-0.17 (-9.21%)
At close:
1.7 USD
-0.03 (-1.45%)
After Hours:
EIGR Earnings overview
Past quarterly earnings results for EIGER BIOPHARMACEUTICALS INC (EIGR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- N/A
- Period
- Q1 / 2024
- EPS Estimate
- -$5.51
- Revenue Estimate
- 5.659M
Last Reported
Most Recent- Release Date
- May 11, 2023
- Period
- Q4 / 2023
- EPS Reported
- EPS Surprise
- %
- Revenue Surprise
- -42.46%
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2023 | -7.65 | - | 55.26% | 3.803M | 6.609M | -42.46% | 40.85% | |
| Q3 2023 | -12.30 | -9.90 | -24.19% | -1,883.87% | 3.21M | 5.014M | -35.98% | -20.15% |
| Q2 2023 | -14.10 | -12.55 | -12.39% | -2,664.71% | 4.64M | 4.66M | -0.43% | 13.45% |
| Q1 2023 | -15.60 | -14.47 | -7.78% | -2,337.50% | 4.118M | 4.244M | -2.97% | 54.23% |
| Q4 2022 | -17.10 | -16.63 | -2.80% | -2,571.88% | 2.7M | 4.523M | -40.31% | -19.64% |
| Q3 2022 | -0.62 | -0.53 | -16.58% | 4.62% | 4.02M | 4.356M | -7.71% | 32.24% |
| Q2 2022 | -0.51 | -0.62 | 17.56% | 10.53% | 4.09M | 4.775M | -14.35% | 94.76% |
| Q1 2022 | -0.64 | -0.66 | 2.46% | -25.49% | 2.67M | 4.118M | -35.16% | -26.85% |
| Q4 2021 | -0.64 | -0.65 | 1.93% | -12.28% | 3.36M | 3.411M | -1.50% | - |
| Q3 2021 | -0.65 | -0.57 | -13.59% | -25.00% | 3.04M | 2.996M | 1.47% | - |
| Q2 2021 | -0.57 | -0.56 | -2.13% | 5.00% | 2.1M | 2.197M | -4.42% | - |
| Q1 2021 | -0.51 | -0.02 | -2,018.64% | 17.74% | 3.65M | 13.265M | -72.48% | - |
| Q4 2020 | -0.57 | 0.26 | -321.03% | - | 24.251M | -100.00% | - | |
| Q3 2020 | -0.52 | -0.60 | 13.30% | - | 1.632M | -100.00% | - | |
| Q2 2020 | -0.60 | -0.73 | 17.54% | - | - | - | ||
| Q1 2020 | -0.62 | -0.82 | 24.27% | - | 637.5K | -100.00% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A
Revenue beat statistics
Revenue beat (4)
0
Average Revenue beat (4)
-20.45%
Max Revenue beat (4)
-0.43%
Min Revenue beat (4)
-42.46%
Analysis
EIGR has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, EIGR reported -20.4% below the revenue estimates on average.
Related analysis
EIGER BIOPHARMACEUTICALS INC / EIGR Earnings FAQ
Can you provide information on whether EIGER BIOPHARMACEUTICALS INC beat earnings estimates in the last quarter?
EIGER BIOPHARMACEUTICALS INC (EIGR) missed EPS estimates and missed revenue estimates in the most recent quarter.